Akhil Kapoor

Oncology — Tata Memorial Hospital, India

LeadR Profile

Akhil Kapoor Tata Memorial Hospital India
454 ScienceLeadR Reputation 454
Network Map

Oncology

Subspecialties: Surgery - Geriatrics - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Tata Memorial Hospital

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The microbiome and its impact on the epigenome in cancer.
dysbiosis, genes, neoplasms, epigenome, therapeutics
Front Epigenet Epigenom20260
Beyond the tumor: cluster of difficult-to-treat (DTR) Klebsiella pneumoniae infection in cancer patients-healthcare-associated outbreak investigations.
neoplasms, klebsiella, palliative care, klebsiella pneumoniae, infections
Support Care Cancer20260
Metastatic Uterine Sarcomas: A Retrospective Analysis on Clinical Outcomes and Biology.
sarcoma, sarcoma, endometrial stromal, therapeutics, prognosis
Cureus20260
Primary Ewing Sarcoma of the Lung: Integrative Analysis of Clinical, Histopathological, Immunohistochemical, and Cytogenetic Features with Literature Review.
diagnosis, differential, genes, sarcoma, ewing, lung, neoplasms, sarcoma, diagnosis, cytogenetics
Indian J Surg Oncol20261
KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.
genes, ras, neoplasms, carcinoma, non-small-cell lung, therapeutics, mutation
Med Oncol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of First Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C Mutant Non small Cell Lung Cancer
NCT06119581 — cells, carcinoma, bronchogenic, pemetrexed, lung, thoracic neoplasms, respiratory tract diseases, respiratory tract neoplasms, antineoplastic agents, neoplasms, carcinoma, non-small-cell lung, drug therapy, neoplastic processes, lung neoplasms, neoplasm metastasis, small cell lung carcinoma, neoplasms by site, therapeutics, lung diseases, pathologic processes, carboplatin, mutation, bronchial neoplasms, chemotherapy, carcinoma
Phase 3Recruiting2023

LeadR Networks

Main global connection map